PAKOLA STEVE (Chief Medical Officer) sold 1.0% of their position (2.16K shares) of REGENXBIO INC. on the open market
Open‑market sale worth $29.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/6/2026ACC: 0001700659-26-000014
Officer· Chief Medical Officer
Since Apr 2019
-2.16K
Net shares
Net seller
$29.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.16K acquired · 4.32K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.16K
Price / share
$7.86
Trade value
$16.99K
% of position
1.0%
7/2/2026
213.01K→215.17K
Common Stock
Direct
Shares
−2.16K
Price / share
$13.64
Trade value
$29.48K
% of position
1.0%
7/2/2026
215.17K→213.01K
Total
Net shares
+0.00
Net value
-$12.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/2/2026 | M · Option Exercise | +2.16K | $7.86 | $16.99K | 1.0% | 213.01K | 215.17K |
| Common Stock Direct | 7/2/2026 | S · Sale | −2.16K | $13.64 | $29.48K | 1.0% | 215.17K | 213.01K |
| Total | +0.00 | -$12.49K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
2.16K shares
Shares
−2.16K
Strike price
7.86
Held after
64.81K
Exercisable
—
7/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock2.16K shares | 7/2/2026 | M · Option Exercise | −2.16K | 7.86 | — | 64.81K |